I’m not an expert on the topic but here’s an analogy: Software used to be much more expensive to bu...
TL;DR · AI 摘要
AI降低软件和药物研发成本，使小工具开发与早期探索更可行，提升试错效率。
核心要点
- AI显著降低软件开发成本，使小型工具开发更具经济合理性
- 在药物研发中，AI优化候选方向，提高发现阶段效率
- AI不能跳过临床试验，但能提升试验选择的准确性
Software used to be much more expensive to build. With AI, everyone agrees writing code and building software is easier and cheaper.
This means it’s more justified to build small tools or solve problems that weren’t worth" / X
Aadit Sheth on X: "I’m not an expert on the topic but here’s an analogy: Software used to be much more expensive to build. With AI, everyone agrees writing code and building software is easier and cheaper. This means it’s more justified to build small tools or solve problems that weren’t worth" / X
Don’t miss what’s happening
I’m not an expert on the topic but here’s an analogy: Software used to be much more expensive to build. With AI, everyone agrees writing code and building software is easier and cheaper. This means it’s more justified to build small tools or solve problems that weren’t worth solving before. More iterations, more solutions, more routes and directions. Same thing with drug development. More routes, more candidates, more shots on goal. The biggest gains are in discovery. AI won’t skip clinical trials, but it’ll make sure we’re running the right ones.
·
3
1
11